MRI risk assessment for liver cancer in chronic liver disease
Part of Cancer, Digestive system clinical trials.
This study uses special MRI scans to better predict liver cancer risk in people with chronic liver disease. It may help doctors identify high-risk patients earlier and improve monitoring.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have chronic liver disease with mild to moderate liver damage (Child-Pugh A or B).
- You meet the high-risk criteria for liver cancer as defined by current medical guidelines.
- You have had a special MRI scan with a contrast agent called Gd-EOB-DTPA.
- You have follow-up health data available for at least 5 years.
- You are not claustrophobic, have no severe kidney problems, and have not had liver surgery before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study aims to predict the risk of developing liver cancer in people with chronic liver conditions such as hepatitis B or C, cirrhosis, or fatty liver disease. By participating, you may help researchers improve early detection and prevention strategies for liver cancer.
This trial compares two types of scans to see which detects liver cancer better in people at high risk. You would receive either an MRI with contrast or an ultrasound every 6 months to monitor for liver cancer.
This study looks at MRI images taken as part of routine care to see if they can help predict future health problems in people with liver disease. If you already have an MRI scheduled for clinical reasons, this may help doctors better estimate risk over time.
This study tests a quicker MRI screening approach for people with cirrhosis to look for liver cancer early. It may help make liver cancer checkups faster and easier while still finding cancers when they are small.
This study uses a special MRI scan to measure liver stiffness before surgery to remove liver tumors. The goal is to see if this scan can help predict surgical risks and improve outcomes for patients undergoing liver surgery.
This study compares MRI and ultrasound to see which is better at finding liver cancer early in people with liver cirrhosis. It also looks at body composition and other factors that could lead to worsening liver function.
Hear when a new Cirrhosis； Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.